During the past decade, University of South Florida- Dept. of Psychiatry and Neurosciences conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of South Florida- Dept. of Psychiatry and Neurosciences" #1 sponsor was "Supernus Pharmaceuticals, Inc." with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Shire" with 2 trials sponsored, "Sunovion" with 2 trials sponsored and "CeNeRx BioPharma Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Florida- Dept. of Psychiatry and Neurosciences" #1 collaborator was "Pfizer" with 1 trials as a collaborator, "University of Pennsylvania" with 1 trials as a collaborator and "University of South Florida" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of South Florida- Dept. of Psychiatry and Neurosciences" are "Attention Deficit Hyperactivity Disorder (ADHD)" (4 trials), "Depressive Disorder, Major" (3 trials), "Schizophrenia" (2 trials), "ADHD" (1 trials) and "Anhedonia" (1 trials). Many other conditions were trialed in "University of South Florida- Dept. of Psychiatry and Neurosciences" in a lesser frequency.

Most popular intervention types in "University of South Florida- Dept. of Psychiatry and Neurosciences" are "Drug" (17 trials), "Behavioral" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "SPN-810" (3 trials), "Aticaprant" (2 trials), "SPD489" (2 trials) and "200mg SPN-812" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of South Florida- Dept. of Psychiatry and Neurosciences" are 17 trials for "All" genders.

Currently, there are NaN active trials in "University of South Florida- Dept. of Psychiatry and Neurosciences". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of South Florida- Dept. of Psychiatry and Neurosciences, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of South Florida- Dept. of Psychiatry and Neurosciences, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".